Thyroid Cancer News
The daily thyroid cancer news is a unique cancer news service that evaluates all aspects of thyroid cancer research and reports on the developments that are most important to cancer patients and health care providers. The daily cancer news provides information about emerging options for thyroid cancer prevention, early detection and thyroid cancer treatment, as well as advances in supportive care and personalized medicine. Supportive care improves quality of life by making thyroid cancer treatment more tolerable, and personalized medicine offers the potential for improved treatment outcomes by using specific characteristics of the patient or the cancer to guide cancer treatment decisions. In addition, interested individuals can search the Cancer Consultants Thyroid Cancer News Archives to find the results of the cancer studies that led to the care they have been offered.
Thyroid Cancer News
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)
People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying... Continue Reading
The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the... Continue Reading
Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National... Continue Reading
The targeted drug Caprelsa® (vandetanib) delays progression in advanced differentiated thyroid cancer, according to the results of a study published in The Lancet Oncology. The thyroid is a gland in the... Continue Reading
A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study... Continue Reading
Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according... Continue Reading
Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean... Continue Reading
A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing... Continue Reading
Live Web Chat with Barrie R. Cassileth, PhD, Chief, Integrative Medicine Service; Laurance S. Rockefeller Chair Integrative Medicine, Memorial Sloan-Kettering Cancer Center (MSKCC), click here for Dr.... Continue Reading
In a Phase III clinical trial, the investigational drug cabozantinib significantly delayed the progression of advanced medullary thyroid cancer. Detailed results are expected to be presented at an upcoming... Continue Reading
Latest Thyroid Cancer News By Stage
General
Selumetinib May Reverse Radioiodine Resistance in Advance Thyroid Cancer (March 28, 2013)
The experimental drug selumetinib (AZD6244) may help some patients with advanced thyroid cancer overcome resistance to radioiodine, which is the most effective treatment for the disease, according to the results of a study published in the New England... Continue Reading
Gene Expression Test Identifies Low-Risk Thyroid Nodules (June 28, 2012)A new test measures gene expression in thyroid nodules with inconclusive biopsy results and helps identify low-risk nodules, thereby preventing unnecessary surgeries, according to the results of a study published early online in the New England Journal... Continue Reading
Low-Dose Radioiodine Effective in Thyroid Cancer (May 10, 2012)Low-dose radioiodine is as effective as high-dose in the treatment of thyroid cancer, according to the results of two separate studies published in the New England Journal of Medicine. The results mean that radiation doses could be cut to one-third of... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Cabozantinib Shows Benefit in Medullary Thyroid Cancer (October 28, 2011)In a Phase III clinical trial, the investigational drug cabozantinib significantly delayed the progression of advanced medullary thyroid cancer. Detailed results are expected to be presented at an upcoming medical conference. Medullary thyroid cancers... Continue Reading
More General
